S&P 500   3,095.14 (+0.11%)
DOW   27,750.08 (+0.21%)
QQQ   201.60 (+0.03%)
CGC   18.67 (-3.01%)
BABA   182.02 (-2.65%)
GE   11.30 (-1.05%)
T   39.15 (-0.05%)
F   8.88 (-1.77%)
ACB   3.52 (-1.40%)
BAC   32.77 (-1.00%)
DIS   141.97 (+2.45%)
S&P 500   3,095.14 (+0.11%)
DOW   27,750.08 (+0.21%)
QQQ   201.60 (+0.03%)
CGC   18.67 (-3.01%)
BABA   182.02 (-2.65%)
GE   11.30 (-1.05%)
T   39.15 (-0.05%)
F   8.88 (-1.77%)
ACB   3.52 (-1.40%)
BAC   32.77 (-1.00%)
DIS   141.97 (+2.45%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stemline TherapeuticsAvedroMagenta TherapeuticsVerrica PharmaceuticalsAMAG Pharmaceuticals
SymbolNASDAQ:STMLNASDAQ:AVDRNASDAQ:MGTANASDAQ:VRCANASDAQ:AMAG
Price Information
Current Price$9.66$23.25$10.31$14.68$9.62
52 Week RangeBuyHoldBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$25.00$23.60$19.00$23.00$13.86
% Upside from Price Target158.80% upside1.51% upside84.29% upside56.68% upside44.05% upside
Trade Information
Market Cap$406.59 million$397.02 million$410.69 million$391.52 million$318.07 million
Beta1.35N/A3.124.120.35
Average Volume626,227138,482125,73655,394907,005
Sales & Book Value
Annual Revenue$500,000.00$27.67 millionN/AN/A$474 million
Price / Sales849.2314.72N/AN/A0.69
CashflowN/AN/AN/AN/A$1.62 per share
Price / CashN/AN/AN/AN/A5.94
Book Value$1.32 per shareN/A$4.39 per share$3.48 per share$21.62 per share
Price / Book7.32N/AN/A0.44
Profitability
Net Income$-85,020,000.00$-25,120,000.00$-57,510,000.00$-20,650,000.00$-65,760,000.00
EPS($2.99)($17.97)($3.13)($1.41)($3.88)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-81.59%N/AN/A-88.54%
Return on Equity (ROE)-102.16%-162.76%-42.16%-35.11%-34.59%
Return on Assets (ROA)-78.50%-47.16%-38.76%-33.59%-19.11%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%0.46%N/AN/A0.58%
Current Ratio4.71%8.41%18.41%17.10%1.67%
Quick Ratio4.57%7.89%18.41%17.10%1.53%
Ownership Information
Institutional Ownership Percentage83.40%68.89%63.98%34.99%N/A
Insider Ownership Percentage13.10%N/A10.90%40.20%4.90%
Miscellaneous
Employees921225916467
Shares Outstanding43.96 million17.52 million39.34 million25.78 million33.91 million
Next Earnings Date3/20/2020 (Estimated)3/19/2020 (Estimated)11/14/2019 (Estimated)3/5/2020 (Estimated)2/6/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Stemline TherapeuticsAvedroMagenta TherapeuticsVerrica PharmaceuticalsAMAG Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel